| pubmed-article:8222365 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8222365 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8222365 | lifeskim:mentions | umls-concept:C0006675 | lld:lifeskim |
| pubmed-article:8222365 | lifeskim:mentions | umls-concept:C0011947 | lld:lifeskim |
| pubmed-article:8222365 | lifeskim:mentions | umls-concept:C0006681 | lld:lifeskim |
| pubmed-article:8222365 | lifeskim:mentions | umls-concept:C2267031 | lld:lifeskim |
| pubmed-article:8222365 | lifeskim:mentions | umls-concept:C0205251 | lld:lifeskim |
| pubmed-article:8222365 | lifeskim:mentions | umls-concept:C0031140 | lld:lifeskim |
| pubmed-article:8222365 | lifeskim:mentions | umls-concept:C1514873 | lld:lifeskim |
| pubmed-article:8222365 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:8222365 | pubmed:dateCreated | 1993-12-21 | lld:pubmed |
| pubmed-article:8222365 | pubmed:abstractText | In the present study we investigated the requirement of low calcium dialysate in 35 patients on continuous ambulatory peritoneal dialysis (CAPD) receiving calcium carbonate as the sole phosphate binder over a 12-month period. Patients with corrected serum calcium > or = 2.85 mmol/L after switching to oral calcium carbonate were given 1 to 3 2-litre exchanges of 2.5 mEq/L calcium dialysate. Serum phosphate level dropped from the pretreatment value of 2.95 +/- 0.62 to a level of between 1.70 +/- 0.41 to 2.03 +/- 0.44 mmol/L 2 weeks after therapy. Corrected serum calcium level increased significantly from 2 weeks onwards. Serum alkaline phosphatase rose initially at 2 and 6 weeks and decreased from 3 months onwards. Serum parathyroid hormone level dropped significantly from a mean pretreatment level of 569 to 320 pg/ml after 12 months (p < 0.001). Serum aluminum decreased significantly from a mean of 1.04 to 0.65 umol/L (p < 0.01). Daily calcium carbonate requirement fluctuated but tended to increase till 8 months and plateaued and ranged from 2.61 +/- 0.57 to 3.98 +/- 2.11 gm. The daily requirement of low calcium dialysate followed a similar trend with approximately three-quarters of patients ultimately requiring at least 1 bag of low calcium dialysate. Eight patients did not require low calcium dialysate. Patients who required low calcium dialysate were significantly older, had a significantly lower pretreatment serum parathyroid hormone and higher serum aluminum levels than those who did not.(ABSTRACT TRUNCATED AT 250 WORDS) | lld:pubmed |
| pubmed-article:8222365 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8222365 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8222365 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8222365 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8222365 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8222365 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8222365 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8222365 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8222365 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8222365 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8222365 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8222365 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:8222365 | pubmed:issn | 0301-0430 | lld:pubmed |
| pubmed-article:8222365 | pubmed:author | pubmed-author:RobinsonJ DJD | lld:pubmed |
| pubmed-article:8222365 | pubmed:author | pubmed-author:ChungC WCW | lld:pubmed |
| pubmed-article:8222365 | pubmed:author | pubmed-author:ChangE SES | lld:pubmed |
| pubmed-article:8222365 | pubmed:author | pubmed-author:TamS CSC | lld:pubmed |
| pubmed-article:8222365 | pubmed:author | pubmed-author:ChanC YCY | lld:pubmed |
| pubmed-article:8222365 | pubmed:author | pubmed-author:CheungW CWC | lld:pubmed |
| pubmed-article:8222365 | pubmed:author | pubmed-author:LoW KWK | lld:pubmed |
| pubmed-article:8222365 | pubmed:author | pubmed-author:LuH BHB | lld:pubmed |
| pubmed-article:8222365 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8222365 | pubmed:volume | 40 | lld:pubmed |
| pubmed-article:8222365 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8222365 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8222365 | pubmed:pagination | 100-5 | lld:pubmed |
| pubmed-article:8222365 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8222365 | pubmed:meshHeading | pubmed-meshheading:8222365-... | lld:pubmed |
| pubmed-article:8222365 | pubmed:meshHeading | pubmed-meshheading:8222365-... | lld:pubmed |
| pubmed-article:8222365 | pubmed:meshHeading | pubmed-meshheading:8222365-... | lld:pubmed |
| pubmed-article:8222365 | pubmed:meshHeading | pubmed-meshheading:8222365-... | lld:pubmed |
| pubmed-article:8222365 | pubmed:meshHeading | pubmed-meshheading:8222365-... | lld:pubmed |
| pubmed-article:8222365 | pubmed:meshHeading | pubmed-meshheading:8222365-... | lld:pubmed |
| pubmed-article:8222365 | pubmed:meshHeading | pubmed-meshheading:8222365-... | lld:pubmed |
| pubmed-article:8222365 | pubmed:meshHeading | pubmed-meshheading:8222365-... | lld:pubmed |
| pubmed-article:8222365 | pubmed:meshHeading | pubmed-meshheading:8222365-... | lld:pubmed |
| pubmed-article:8222365 | pubmed:meshHeading | pubmed-meshheading:8222365-... | lld:pubmed |
| pubmed-article:8222365 | pubmed:meshHeading | pubmed-meshheading:8222365-... | lld:pubmed |
| pubmed-article:8222365 | pubmed:meshHeading | pubmed-meshheading:8222365-... | lld:pubmed |
| pubmed-article:8222365 | pubmed:meshHeading | pubmed-meshheading:8222365-... | lld:pubmed |
| pubmed-article:8222365 | pubmed:meshHeading | pubmed-meshheading:8222365-... | lld:pubmed |
| pubmed-article:8222365 | pubmed:meshHeading | pubmed-meshheading:8222365-... | lld:pubmed |
| pubmed-article:8222365 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8222365 | pubmed:articleTitle | The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder. | lld:pubmed |
| pubmed-article:8222365 | pubmed:affiliation | Department of Medicine, University of Hong Kong. | lld:pubmed |
| pubmed-article:8222365 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8222365 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
